Loading...
TILT Holdings Inc.
TILT.NE•NEO
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.01
CA$0.00(0.00%)
TILT Holdings Inc. (TILT.NE) Financial Performance & Income Statement Overview
Review TILT Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-30.33%
↓ 30.33%
Operating Income Growth
-60.90%
↓ 60.90%
Net Income Growth
-52.10%
↓ 52.10%
Operating Cash Flow Growth
-103.52%
↓ 103.52%
Operating Margin
-70.03%
↓ 70.03%
Gross Margin
16.59%
↑ 16.59%
Net Profit Margin
-102.40%
↓ 102.40%
ROE
623.35%
↑ 623.35%
ROIC
-278.62%
↓ 278.62%
TILT Holdings Inc. (TILT.NE) Income Statement & Financial Overview
Review TILT Holdings Inc.'s (TILT.NE) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $22.73M | $24.56M | $26.97M | $26.58M |
| Cost of Revenue | $19.33M | $19.28M | $23.17M | $22.32M |
| Gross Profit | $3.39M | $5.28M | $3.79M | $4.26M |
| Gross Profit Ratio | $0.15 | $0.22 | $0.14 | $0.16 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.40M | $7.14M | $7.42M | $8.17M |
| Operating Expenses | $9.96M | $38.35M | $11.27M | $27.76M |
| Total Costs & Expenses | $29.29M | $57.63M | $34.44M | $50.08M |
| Interest Income | $0.00 | $972.00 | $0.00 | $1000.00 |
| Interest Expense | -$7.56M | $6.87M | $6.68M | $6.79M |
| Depreciation & Amortization | $2.62M | $5.34M | $3.86M | $5.68M |
| EBITDA | -$18.33M | -$27.67M | -$3.62M | -$18.008M |
| EBITDA Ratio | -$0.81 | -$1.13 | -$0.13 | -$0.68 |
| Operating Income | -$6.57M | -$33.06M | -$7.48M | -$23.50M |
| Operating Income Ratio | -$0.29 | -$1.35 | -$0.28 | -$0.88 |
| Other Income/Expenses (Net) | -$6.53M | -$6.81M | -$6.58M | -$6.28M |
| Income Before Tax | -$13.10M | -$39.88M | -$14.05M | -$29.78M |
| Income Before Tax Ratio | -$0.58 | -$1.62 | -$0.52 | -$1.12 |
| Income Tax Expense | -$144000.00 | $1.54M | $1.41M | $6.17M |
| Net Income | -$13.24M | -$41.42M | -$12.65M | -$35.95M |
| Net Income Ratio | -$0.58 | -$1.69 | -$0.47 | -$1.35 |
| EPS | -$0.03 | -$0.11 | -$0.03 | -$0.09 |
| Diluted EPS | -$0.03 | -$0.11 | -$0.03 | -$0.09 |
| Weighted Avg Shares Outstanding | $391.25M | $391.23M | $389.52M | $388.48M |
| Weighted Avg Shares Outstanding (Diluted) | $391.25M | $391.23M | $389.52M | $388.48M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan